Mostrar el registro sencillo del ítem

2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19

dc.contributor.authorAlunno, Alessia
dc.contributor.authorNajm, Aurelie
dc.contributor.authorMachado, Pedro M.
dc.contributor.authorRodríguez Carrio, Javier 
dc.date.accessioned2022-06-29T08:16:10Z
dc.date.available2022-06-29T08:16:10Z
dc.date.issued2021
dc.identifier.citationAnnals of the Rheumatic Diseases (2021); doi:10.1136/annrheumdis-2021-221366
dc.identifier.issn0003-4967
dc.identifier.issn1468-2060
dc.identifier.urihttp://hdl.handle.net/10651/63565
dc.description.sponsorshipEuropean Alliance of Associations in Rheumatology (EULAR) [CLI122]; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); NIHR Newcastle Biomedical Research Centre in Ageing and Long-Term Conditions; Research Into Inflammatory Arthritis Centre vs Arthritis (...)
dc.description.statementofresponsibilityAlunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes IB, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X.
dc.language.isoeng
dc.relation.ispartofAnnals of the rheumatic diseases
dc.rights© 2022 Los autores
dc.sourceWOS:000722667300001
dc.title2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
dc.typejournal article
dc.identifier.doi10.1136/annrheumdis-2021-221366
dc.relation.publisherversionhttp://dx.doi.org/10.1136/annrheumdis-2021-221366


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem